May. 11, 2022
What’s the key to being a leader in the industry?
WuXi Biologics
Offering End-to-End Solutions
Perspectives
-
-
Mar. 04, 2022The Watershed Moment for ADCs has Arrived -
Dec. 15, 2021The benefits of using a single-source for discovery, development and GMP manufacture of antibody drug conjugates and other novel bioconjugates -
Dec. 01, 2021Streamline the ADC Path to the Clinic with One-stop Drug Development and Critical Technology Advancements -
Dec. 29, 2020Applications and Impact of CRISPR/Cas9 in Bioprocessing -
Sep. 16, 2020Reducing Fill Risk in Drug Product Manufacture Utilizing New State-of-the-Art Systems and Platforms -
Sep. 10, 2021The Challenge of Staying Current with Regulatory Changes – How one company is providing a solution -
Aug. 10, 2021Continuous Biomanufacturing Implementation Using an Intensified and Integrated Bioprocess Platform -
Apr. 20, 2020Fierce Pharma Virtual Series – Expert Panel Discussion Featuring Chris Chen
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?